AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $47.07 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.